Adult Vaccinations

STATEN ISLAND, N.Y. , Nov. 11, 2020 /PRNewswire/ -- Beacon Christian Community Center has been listed as one of the recommended flu vaccination pop-up sites across the city by the NYC Department of Health. While vaccinations for seasonal flu will be readily available, Beacon will also provide vaccines for HPV, Hepatitis B, Pneumonia, Menveo, Measles, Mumps, Rubella and Whooping Cough. Continue Reading Beacon Christian Community Health Center Inc. "With the impending spread of coronavirus, it's important now more than ever to get vaccinated. The health of our immune system this flu season is imperative, especially as the months get colder and winter approaches," said Dr. David Kim , CEO, Beacon Christian Community Health Center. "The DOH estimates that roughly 2,000 New Yorkers die of seasonal flu and its complications. A number that we can all agree is too high. These pop-up sites make vaccinations readily accessible and limit the added risks presented...

The global hunt for a COVID-19 vaccine for kids is only just beginning — a lagging start that has some U.S. pediatricians worried they may not know if any shots work for young children in time for the next school year. Older adults may be most vulnerable to the coronavirus, but ending the pandemic will require vaccinating children, too. Last week, Pfizer Inc. received permission to test its vaccine in U.S. kids as young as 12, one of only a handful of attempts around the world to start exploring if any experimental shots being pushed for adults also can protect children. “I just figured the more people they have to do tests on, the quicker they can put out a vaccine and people can be safe and healthy,” said 16-year-old Katelyn Evans, who became the first teen to get an injection in the Pfizer study at Cincinnati Children’s Hospital. Multiple vaccine candidates are in final-stage studies in tens of thousands of adults, and scientists are hopeful that the next few months will bring e...

Even with encouraging early results from a Pfizer coronavirus vaccine candidate, it will be many months before a vaccine is widely available. Here's why. NOEL KING, HOST: All right, two significant numbers having to do with COVID-19 - 10 million - that's the number of confirmed cases in the U.S., and it's going up - and 90% - that's how effective Pfizer says its coronavirus vaccine is in preventing symptomatic cases of COVID-19. So does this mean we could have a vaccine soon? NPR's Selena Simmons-Duffin is here with a reality check. SELENA SIMMONS-DUFFIN, BYLINE: The truth is that widespread vaccination is many months away. That may seem strange. Everything about this vaccine has been fast. So why can't we go from promising results to vaccines for all right away? There are a few reasons. The first is that these results are preliminary. Pfizer will gather and present more data on efficacy and safety to the Food and Drug Administration. That's, best-ca...

[unable to retrieve full-text content] Federal government approves South Carolina’s vaccination distribution plan    WIS10

Despite promising news about an experimental COVID-19 vaccine, many logistical questions remain for local health departments in Wisconsin.  On Monday, drugmaker Pfizer announced its experimental COVID-19 vaccine has been found to be 90 percent effective . But in Wisconsin, the planning for how an eventual vaccine will be distributed and by whom is still in the early stages.  In a Monday press release , the Wisconsin Department of Health Services encouraged health providers to enroll in the state's COVID-19 Vaccine Program if they plan to administer vaccines once one becomes available to the public.  "We are urging providers that plan on providing COVID-19 vaccines to enroll in the program as early as possible," said DHS Deputy Secretary Julie Willems Van Dijk . "The earlier we start enrolling vaccinators, the more prepared we will be when a safe and effective COVID-19 vaccine becomes available." La Crosse County Health Department media specialist Abbie Lo...

(Ecofin Agency) - The government of Morocco said it will launch a vaccination campaign against Covid-19 as of November 15. According to local sources, the vaccine is developed by the Chinese pharmaceutical company Sinopharm. As a reminder, the two partners reached an agreement in late August for phase III clinical trials. According to a statement issued yesterday by the government, the vaccine will first be administered to frontline workers aged above 18 (health workers, public authorities, security forces, national education personnel) according to a two-injection vaccination schedule. From December, the program will target people at risk, including people aged above 65 and those diagnosed with chronic diseases. The rest of the population will follow. The project aligns with the strategy put in place by King Mohamed VI who swiftly deployed a response plan when the pandemic broke out. While the country is gradually recovering economically and socially, the government now wants to b...

When a safe and effective vaccine for COVID-19 finally becomes available to the public, it’s almost guaranteed that supplies will initially be limited. Therefore, officials will need to make tough calls about who to inoculate against the coronavirus first, with at-risk groups and frontline workers often being named as frontrunners. But, Wired reports , some experts argue that a different group should cut the line and get the first doses of the vaccine: the very same social butterfly superspreaders responsible for new outbreaks and infections. The argument, according to Wired , is that inoculating the most flagrant violators of distancing and quarantine protocols, regardless of whether it’s by choice or the necessity of their jobs, would more directly combat the coronavirus pandemic based on how it’s actually spread. Because it’s an unfortunate reality that older people tend to have fewer interpersonal connections, Wired reports that prioritizing them in a vaccination program woul...